Takeaway
Patients diagnosed with multiple sclerosis (MS) should be monitored for depression and treated appropriately.
Why this matters
Current evidence shows that the prevalence of depression in patients with MS is high (up to 30% at the time of diagnosis and up to 60% after diagnosis) but data on the rate of new depression after MS diagnosis and during disease progression are lacking.